Frost & Sullivan to Host Complimentary Web Conference: Will the U.S. Implantable Defibrillator Market Recover?
LONDON, June 6, 2012 /PRNewswire/ — Western Europe and the United States are the biggest markets for Implantable Cardioverter Defibrillator. The Implantable Cardioverter Defibrillator is one of the most challenging and dynamic markets in the United States. 2011 witnessed one of the major dips in the unit sales of ICD in the U.S. Together with the decreasing pricing trends, the market for ICD in the U.S. decreased to new levels. This web conference will cover the key reasons for the dropdown of ICD unit sales in the U.S. and also a comparative analysis with some trends in the ICD market in Western European countries.
Frost & Sullivan will host a complimentary web conference entitled “Will the U.S. Implantable Defibrillator Market Recover,” which will take place on Wednesday 13(th) June 2012 at 2.00 pm BST. Research Analyst Brahadeesh Chandrasekaran has completed extensive analysis on the Implantable Cardioverter Defibrillator market. The research expert will lead a short teleconference about new findings that affect the market, followed by a live question-and-answer session. Highlights of the web conference will include heart failure, implantable cardioverter defibrillator, implantation, cardiac devices and cardiac rhythm management.
To participate in this complimentary web conference, please email Janique Morvan, Corporate Communications at firstname.lastname@example.org, with your full contact details. Upon receipt of the above-mentioned information, a registration link will be emailed to you.
This web conference will benefit the cardiac rhythm management industry and manufacturers by discussing the various reasons for the market decline in 2011 and the response from physicians, electrophysiologists for implantation and guidelines.
“The publication of non-evidence based ICD implantation has triggered down the market for ICD in the U.S. The results from this study have been highly influential and has raised the questions on guidelines being followed by the medical professionals,” observes Brahadeesh Chandrasekaran. “The study in the United States has created the curiosity at a Western European level, the second biggest market ICDs in the world.”
To receive a link of the recorded web conference and / or further information on this research, please email Janique Morvan at email@example.com with your full contact details.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360-degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Corporate Communications – Europe
P: +33 (0)1 42 81 20 37
M: +33 (0)6 79 22 41 42
SOURCE Frost & Sullivan